skip to content
Home

Cambridge Immunology Network

 

Cambridge leads national drug trial to prevent deaths after COVID-19 patients leave hospital

Submitted by J.M. Arasteh on Thu, 25/03/2021 - 10:17

A UK-wide study is being launched to reduce the number of people who die in the months following a stay in hospital with COVID-19.

The clinical trial - named HEAL-COVID - also aims to cut the number of patients being readmitted to hospital with complications as a result of having COVID.

Read the original article here>

Contact us

Cambridge Immunology Network Coordinator

University of Cambridge Department of Medicine,
Jeffrey Cheah Biomedical Centre,
Cambridge Biomedical Campus, Puddicombe Way,
Cambridge, CB2 0AW

Contact: webmaster@immunology.cam.ac.uk

Site Privacy & Cookie Policies

 Follow us on Twitter

Watch our webinars

Sign up to our newsletter

We are a FOCIS centre of Excellence

FCEs provide interdisciplinary training programmes for students, fellows and continuing education physicians through FOCIS assisted opportunities

Read more

Study at Cambridge

About the University

Research at Cambridge